Sources of Support and Conflicts of Interest: This study was supported by the Fulbright African Regional Research Program (Meyer), American Academy of Neurology Practice Research Training Fellowship (Meyer), Doris Duke International Clinical Research Fellowship (Cettomai), and American Medical Association Foundation Seed Grant (Cettomai). In addition, this study was supported by the Fogarty International Clinical Research Fellowship (Meyer, Kwasa) (5 R24 TW00798; 3 R24 TW00798-02S1) from the National Institutes of Health, Fogarty International Center through Vanderbilt University, the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), Office of the Director, National Institutes of Health and the National Institute of Mental Health (NIMH). Dr. Deanna Cettomai has received research support from the Doris Duke Charitable Foundation and an NIH/Johns Hopkins Pre-Doctoral Clinical Research Training Program T32 grant. Dr. Judith Kwasa has received research support from the NIH Fogarty International Clinical Research Scholarship. Dr. Gretchen Birbeck has received NIH research support, including travel and meeting attendance related to R01, R21 and K23 awards, as well as research support from the Doris Duke Charitable Fund. Dr. Richard Price has received support from NIH/NIMH research grants, an investigator-initiated research grant from Merck and a lecture honorarium from Abbott. Dr. Craig Cohen has received funds from Osel, Inc. to conduct a Phase 2a clinical trial of LACTIN-V, a vaginal probiotic to prevent recurrent bacterial vaginosis. Ms. Caroline Kendi has nothing to disclose. Dr. Elizabeth Bukusi has received funding from NIH, CDC, the Bill and Melinda Gates Foundation, and the International Partnership for Microbicides. Dr. Ana-Claire Meyer has received research support from the Fulbright African Regional Research Program, NIH Fogarty International Clinical Research Fellowship (5 R24 TW00798; 3 R24 TW00798-02S1). She is currently the recipient of a K01 and R21 from NIH.
Screening for HIV-associated peripheral neuropathy in resource-limited settings
Version of Record online: 27 AUG 2013
Copyright © 2013 Wiley Periodicals, Inc.
Muscle & Nerve
Volume 48, Issue 4, pages 516–524, October 2013
How to Cite
Cettomai, D., Kwasa, J. K., Birbeck, G. L., Price, R. W., Cohen, C. R., Bukusi, E. A., Kendi, C. and Meyer, A.-C. L. (2013), Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve, 48: 516–524. doi: 10.1002/mus.23795
This work was funded by the NIH but is not a US government work, nor is it public domain. It does need to be made available under the public access laws.
- Issue online: 23 SEP 2013
- Version of Record online: 27 AUG 2013
- Accepted manuscript online: 30 JAN 2013 10:50PM EST
- Manuscript Accepted: 14 JAN 2013
Additional Supporting Information may be found in the online version of this article.
|mus23795-sup-0001-suppappendix1.doc||50K||Supplementary Appendix 1.|
|mus23795-sup-0002-suppappendix2.doc||59K||Supplementary Appendix 2.|
|mus23795-sup-0003-suppappendix3.doc||81K||Supplementary Appendix 3.|
|mus23795-sup-0004-suppfig1.tif||2931K||Supplementary Figure 1.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.